Published in Cancer Weekly, November 2nd, 1998
J. Huh et al. investigated the feasibility of using a cell block preparation of Epstein-Barr virus (EBV)-infected Burkitt's lymphoma cell line (EB-3) as a positive control for in situ hybridization (ISH) for EBV-encoded RNA (EBER) ("Cell Block Preparation of a Burkitt's Lymphoma Cell Line as a Positive Control for In Situ Hybridization for Epstein-Barr Virus," Acta Cytologica, September-October 1998;42(5):1144-1148).
The researchers processed EB-3 cells into cell block and cytocentrifuge preparations. They performed ISH for EBER...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.